What is the breakup of the Cell Lysis & Disruption market based on the product type?

San Francisco, California , USA, Sept 15, 2022 — /EPR Network/ —

Cell Lysis & Disruption Industry Overview

The global cell lysis & disruption market size was valued at USD 4.09 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 9.35% from 2021 to 2028.

High adoption of biotechnology processes in bio-services, agricultural, and pharmaceutical industries coupled with a rise in the adoption of gene expression protocols has majorly driven the growth of this market. The ongoing COVID-19 pandemic has positively impacted the market growth. An increase in R&D activities for the development of a vaccine for COVID-19 has augmented the demand for technologies used for bioprocessing, including cell lysis & disruption. Owing to this, key companies shifted their focus on offering bioprocessing-related solutions, in turn, capturing substantial revenue growth.

Growing investments by several organizations including government, as well as private, towards R&D related to biotechnological processes and academics are expected to further drive the market significantly. In addition, a rise in the prevalence of disorders and high demand for novel therapeutics are expected to propel market growth.

Gather more insights about the market drivers, restrains and growth of the Global Cell Lysis & Disruption market

The expansion in the biopharmaceutical industry would provide new growth avenues to the market, as retrieval and purification of biopharmaceuticals involve cell lysis & disruption. Moreover, the adoption of biotech processes in pharmaceutical, agricultural, and bio-services industries is expected to drive the market as cell lysis holds substantial importance in the course of the bioprocess.

The rise in demand for efficient tumor tissue dissociation equipment has led to the development of novel products based on microfluidics. Microfluidic devices are found to be useful in the efficient dissociation of tumor tissues in single cells and thereby enhance cell recovery with respect to number and purity.

Browse through Grand View Research’s Biotechnology Industry Research Reports.

  • Cell Counting Market – The global cell counting market size was valued at USD 7.49 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 8.21% from 2022 to 2030.
  • RNA Analysis Market – The global RNA analysis market size was valued at USD 10.64 billion in 2021 and is anticipated to expand at a compound annual growth rate (CAGR) of 16.59% from 2022 to 2030.

Cell Lysis & Disruption Market Segmentation

Grand View Research has segmented the global cell lysis & disruption market on the basis of technique, product, cell type, application, end use, and region:

Cell Lysis & Disruption Technique Outlook (Revenue, USD Million, 2018 – 2028)

  • Reagent-based
  • Physical Disruption

Cell Lysis & Disruption Product Outlook (Revenue, USD Million, 2018 – 2028)

  • Instruments
  • Reagents & Consumables

Cell Lysis & Disruption Cell Type Outlook (Revenue, USD Million, 2018 – 2028)

  • Mammalian cells
  • Bacterial cells
  • Yeast/Algae/Fungi
  • Plant cells

Cell Lysis & Disruption Application Outlook (Revenue, USD Million, 2018 – 2028)

  • Protein Isolation
  • Downstream Processing
  • Cell Organelle Isolation
  • Nucleic Acid Isolation

Cell Lysis & Disruption End-use Outlook (Revenue, USD Million, 2018 – 2028)

  • Academic & Research Institutes
  • Hospitals & Diagnostic Labs
  • Cell Banks
  • Pharmaceutical & Biotechnology Companies

Cell Lysis & Disruption Regional Outlook (Revenue, USD Million, 2018 – 2028)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

Market Share Insights

  • January 2021: Thermo Fisher Scientific, Inc. acquired Henogen S.A., the viral vector manufacturing business of Novasep. This expanded the company’s capabilities for gene and cell therapies & vaccines as well as enhanced cell lysis and disruption business as it is a part of manufacturing workflow.

Key Companies profiled:

Some prominent players in the global Cell Lysis & Disruption market include

  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Hoffmann-La Roche Ltd.
  • Qiagen NV
  • Becton Dickinson & Company (BD)
  • Danaher Corp.
  • Bio-Rad Laboratories, Inc.
  • Miltenyi Biotec GmbH
  • Claremont BioSolutions, LLC
  • Microfluidics International Corp.
  • Parr Instrument Company
  • BioVision, Inc.
  • Covaris, Inc.
  • Qsonica LLC

Order a free sample PDF of the Cell Lysis & Disruption Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Matched content

Editor’s pick

Express Press Release Distribution